|
PWP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.81737999999099E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11940000047106E-07 |
| Normal-vs-Stage2 |
9.242300E-03 |
| Normal-vs-Stage3 |
9.428800E-01 |
| Normal-vs-Stage4 |
5.221200E-01 |
| Stage1-vs-Stage2 |
5.714400E-01 |
| Stage1-vs-Stage3 |
2.044300E-02 |
| Stage1-vs-Stage4 |
3.514800E-01 |
| Stage2-vs-Stage3 |
9.233900E-02 |
| Stage2-vs-Stage4 |
4.584400E-01 |
| Stage3-vs-Stage4 |
6.054400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.06400000032814E-07 |
| Normal-vs-AfricanAmerican |
5.263500E-02 |
| Normal-vs-Asian |
7.892600E-01 |
| Caucasian-vs-AfricanAmerican |
9.164700E-03 |
| Caucasian-vs-Asian |
2.557400E-01 |
| AfricanAmerican-vs-Asian |
5.031000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.13399999951613E-07 |
| Normal-vs-Female |
1.835190E-01 |
| Male-vs-Female |
1.323660E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.225700E-04 |
| Normal-vs-Extreme_Weight |
1.92060000125949E-08 |
| Normal-vs-Obese |
6.281100E-03 |
| Normal-vs-Extreme_Obese |
1.646260E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.163000E-01 |
| Normal_Weight-vs-Obese |
2.421800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.274200E-01 |
| Extreme_Weight-vs-Obese |
8.739600E-03 |
| Extreme_Weight-vs-Extreme_Obese |
5.965200E-01 |
| Obese-vs-Extreme_Obese |
9.911900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.038400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.89419999999663E-05 |
| Normal-vs-Age(61-80Yrs) |
4.4665999999749E-06 |
| Normal-vs-Age(81-100Yrs) |
2.596800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.016300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.277600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.113780E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.850000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.949700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.528420E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.04110000012747E-07 |
| Normal-VS-Type2 PRCC |
8.34450000000153E-05 |
| Normal-VS-KIRP CIMP |
1.676240E-02 |
| Normal-VS-Unclassified PRCC |
8.998200E-04 |
| Type1 PRCC-VS-Type2 PRCC |
8.551800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.35160005199486E-09 |
| Type1 PRCC-VS-Unclassified PRCC |
8.635200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.73230000003011E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
9.835800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.55327999999955E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.95069999999942E-05 |
| Normal-vs-N1 |
3.844400E-01 |
| Normal-vs-N2 |
3.304800E-01 |
| N0-vs-N1 |
3.338200E-03 |
| N0-vs-N2 |
9.813400E-01 |
| N1-vs-N2 |
1.868600E-01 |
|
|
